Stocks
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.17 | -3.33 | 10.8 | -6.91 | -23.9 | -5.10 | ||
| Changes by years, y/y, % | +89% | -46% | -423% | -164% | +246% | +92.9% | |||
Arcturus Therapeutics Holdings. EV/EBITDA
Arcturus Therapeutics Holdings. EV/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -4.95 | -5.67 | -6.58 | -5.81 | -7.03 | -5.10 | |
| Changes by years, y/y, % | -157% | -166% | -195% | -124% | -169% | |||
| Changes by quarters, q/q, % | -148% | +14% | +16% | -12% | +21% | |||
